Laboratory Smallpox Stocks: Biosecurity Risks and Debate

Primary Risks

  • Bioterrorism: Potential theft or misuse to create a weapon.
  • Accidental Release: Lab escape could spark a pandemic (smallpox is highly contagious, ~30% fatality, no cure).
  • Worker Exposure: Even minimal exposure can be fatal; requires maximum containment (BSL‑4).

Current Status

Smallpox eradicated in 1980. Two WHO‑authorized repositories remain (CDC Atlanta, VECTOR Russia) for research on vaccines, antivirals, diagnostics.

Risk‑Benefit Consideration

Research benefits (improved countermeasures) must be weighed against catastrophic risks. Ongoing debate about destroying remaining stocks versus retaining for preparedness.

Viral Infections - Related Articles